Advanced Flower Capital (AFCG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
4 Mar, 2026Executive summary
Completed conversion from REIT to BDC as of January 1, 2026, expanding investment flexibility and sector reach.
Focused on reducing exposure to underperforming credits and active portfolio management throughout 2025.
Originated $53 million in new commitments in 2025 and closed $89.7 million in new commitments post year-end.
Leadership team with extensive experience in private credit, real estate, and public company management, supporting robust credit discipline and risk management.
2025 dividends characterized as return of capital, making distributions tax-free for shareholders.
Financial highlights
Q4 2025 net interest income: $5.2 million; Distributable Earnings: -$2.8 million (-$0.12/share); GAAP net income: $0.9 million ($0.04/share).
FY 2025 net interest income: $24.6 million; Distributable Earnings: $8.7 million ($0.39/share); GAAP net loss: $20.7 million (-$0.95/share).
FY 2025 interest income: $31.3 million.
Ended Q4 2025 with $317.4 million principal outstanding across 15 loans; as of Feb 25, 2026, $366.4 million across 15 loans.
Total assets at December 31, 2025: $275.6 million; total shareholder equity: $175.6 million.
Outlook and guidance
Board declared Q1 2026 dividend of $0.05/share, payable April 15, 2026.
Active pipeline increased to over $1.4 billion, driven by BDC conversion and expanded investment universe.
Focus remains on redeploying capital from non-accrual loans into performing credits to unlock future earnings.
As a BDC, aims to diversify portfolio across industries and loan types, increasing selectivity and reducing risk.
High bar for new cannabis loans due to regulatory and industry challenges; focus shifting to lower middle market non-cannabis opportunities.
Latest events from Advanced Flower Capital
- Q2 2025 net loss of $13.2M, $3.4M distributable earnings, and BDC conversion planned.AFCG
Q2 202510 Mar 2026 - Q2 net income reached $16.4M as the company became a pure-play cannabis lender.AFCG
Q2 20242 Feb 2026 - Q3 2024 earnings met targets, with strong originations and higher risk post-CRE spin-off.AFCG
Q3 202414 Jan 2026 - Exceeded origination targets, delivered strong yields, and maintained a robust pipeline.AFCG
Q4 202424 Dec 2025 - REIT lender to cannabis sector files $1B shelf registration for flexible equity and debt offerings.AFCG
Registration Filing16 Dec 2025 - Shareholders will vote on director election and auditor ratification, with Board support.AFCG
Proxy Filing2 Dec 2025 - Shareholders to vote on REIT-to-BDC conversion, new advisory agreement, and leverage increase.AFCG
Proxy Filing2 Dec 2025 - Shareholders to vote on REIT-to-BDC conversion and new advisory agreement for expanded flexibility.AFCG
Proxy Filing2 Dec 2025 - Vote on director election and auditor ratification at the May 2025 virtual annual meeting.AFCG
Proxy Filing2 Dec 2025